Tag: KRAS Mutation
Cooley advises Jacobio’s USD2bn licensing deal with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
Cooley has advised Jacobio Pharmaceuticals on a record-breaking USD 2.02 billion global licensing agreement with AstraZeneca
IHCF vice president SongYi Son discusses the merits and possible obstacles for doing business in South Korea
Follow us on LinkedIn